Con ms de 40 aos de experiencia
If the 56-day limit is exceeded, the pen must be discarded, even if doses remain, as the manufacturer cannot guarantee potency or safety beyond this timeframe
The REDEFINE clinical trial program has established that: Cagrilintide 2.4 mg + Semaglutide 2.4 mg weekly produces superior weight loss compared to either agent alone The combination achieved 22.7% mean weight reduction at 68 weeks Side effect profiles were manageable with proper dose escalation The amylin + GLP-1 agonist combination demonstrated synergistic effects This validated combination demonstrates that pairing cagrilintide with incretin-based therapies can work effectively
At our clinic, our team of professionals is dedicated to ensuring you have a clear picture of what lies ahead
At the Ageless Center, we dont just prescribe medications and send you on your way
The G of G/D-CuP decreased from 2500 Pa (0.1% strain) to 390 Pa (1200% strain), but upon strain relief, the G recovered to 2500 Pa (Fig